Selected article for: "dendritic cell and immune system"
Author: Han, Jian; Sun, Jiazhi; Zhang, Guixin; Chen, Hailong
Title: DCs-based therapies: potential strategies in severe SARS-CoV-2 infection
  • Cord-id: pdy8fooz
  • Document date: 2021_1_1
    • ID: pdy8fooz
    Snippet: Pneumonia caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is spreading globally. There have been strenuous efforts to reveal the mechanisms that the host defends itself against invasion by this virus. The immune system could play a crucial role in virus infection. Dendritic cell as sentinel of the immune system plays an irreplaceable role. Dendritic cells-based therapeutic approach may be a potential strategy for SARS-CoV-2 infection. In this review, the characteristic
    Document: Pneumonia caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is spreading globally. There have been strenuous efforts to reveal the mechanisms that the host defends itself against invasion by this virus. The immune system could play a crucial role in virus infection. Dendritic cell as sentinel of the immune system plays an irreplaceable role. Dendritic cells-based therapeutic approach may be a potential strategy for SARS-CoV-2 infection. In this review, the characteristics of coronavirus are described briefly. We focus on the essential functions of dendritic cell in severe SARS-CoV-2 infection. Basis of treatment based dendritic cells to combat coronavirus infections is summarized. Finally, we propose that the combination of DCs based vaccine and other therapy is worth further study.

    Search related documents:
    Co phrase search for related documents
    • acute ards respiratory distress syndrome and low immunogenicity: 1, 2, 3
    • acute disease and administration route: 1, 2, 3, 4
    • acute disease and loss toxicity: 1
    • acute disease and low immunogenicity: 1, 2
    • acute respiratory syndrome and administration route: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low immunogenicity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute virus and administration route: 1, 2, 3
    • acute virus and low immunogenicity: 1, 2
    • administration route and low immunogenicity: 1, 2, 3